Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>CSPC PHARMA Interim NP Drops 15.6% to RMB2.55B; Interim DPS Reduced to $14 Cents
Recommend 6 Positive 9 Negative 7 |
||||
|
||||
|
CSPC PHARMA (01093.HK) announced its interim results for the period ended June 2025. Turnover declined by 18.5% YoY to RMB13.273 billion. Net profit amounted to RMB2.548 billion, down 15.6% YoY, with an EPS of RMB22.29 cents. An interim DPS of $14 cents was declared, compared to $16 cents in the corresponding period of 2024. AAStocks Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
